Showing results (1511-1520 of 1,600) with videos related to
Sort By:
Pageof 160
Chembiochem : a European Journal of Chemical Biology|October 22, 2019
Differential Inhibition of APOBEC3 DNA-Mutator Isozymes by Fluoro- and Non-Fluoro-Substituted 2'-Deoxyzebularine Embedded in Single-Stranded DNAMaksim V Kvach, Fareeda M Barzak, Stefan Harjes, et al.Plos Pathogens|December 22, 2018
A potent Lassa virus antiviral targets an arenavirus virulence determinantIkenna G Madu, Megan Files, Dima N Gharaibeh, et al.Ebiomedicine|March 26, 2025
Cerebrospinal fluid metabolomics in autistic regression reveals dysregulation of sphingolipids and decreased β-hydroxybutyrateJingya Yan, Velda X Han, Hannah F Jones, et al.Journal of Virology|January 18, 2008
Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challengeAklile Berhanu, Rebecca L Wilson, Dana L Kirkwood-Watts, et al.Plos One|November 13, 2014
Role of recurrent hypoxia-ischemia in preterm white matter injury severityMatthew W Hagen, Art Riddle, Evelyn McClendon, et al.The Oncologist|August 18, 2019
A Randomized, Double-Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX-427) in Patients with Previously Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer: The SPRUCE TrialDavid R Spigel, Dianna L Shipley, David M Waterhouse, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2011
Phase 1 study of the safety, tolerability, and pharmacokinetics of TH-302, a hypoxia-activated prodrug, in patients with advanced solid malignanciesGlen J Weiss, Jeffrey R Infante, E Gabriela Chiorean, et al.Clinical Pharmacology and Therapeutics|August 15, 2018
Tumor Drug Penetration Measurements Could Be the Neglected Piece of the Personalized Cancer Treatment PuzzleImke H Bartelink, Ella F Jones, Sheerin K Shahidi-Latham, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2013
Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with advanced cancerJohanna C Bendell, Michael S Gordon, Herbert I Hurwitz, et al.Foodborne Pathogens and Disease|February 2, 2010
Risk factors for sporadic shigellosis, FoodNet 2005Clinton C Haley, Kanyin L Ong, Katrina Hedberg, et al.Pageof 160